FAQ/Help |
Calendar |
Search |
Today's Posts |
|
02-24-2019, 03:04 PM | #1 | ||
|
|||
Junior Member
|
Hi all,
Can any longer term members remember posts from a member who was self-trialing Pirenzepine for a short period of time? I distinctly remember her(?) describing the ongoing sensations, but then she ended the trial. Or am I mis-remembering? Thank you! Paul |
||
Reply With Quote |
"Thanks for this!" says: | Lerch (02-25-2019) |
03-03-2019, 07:45 PM | #2 | ||
|
|||
Junior Member
|
Quote:
Are you going to give it a try?seems to be a harmless drug other than stomach discomfort |
||
Reply With Quote |
03-04-2019, 12:25 AM | #3 | |||
|
||||
Grand Magnate
|
The results of this technical rodent model study look encouraging.
Selective antagonism of muscarinic receptors is neuroprotective in peripheral neuropathy
__________________
Knowledge is power. |
|||
Reply With Quote |
"Thanks for this!" says: | Lerch (03-05-2019) |
03-04-2019, 11:08 PM | #4 | ||
|
|||
Junior Member
|
"Are you going to give it a try?seems to be a harmless drug other than stomach discomfort"
I thought a bit about it, but I've heard that oral administration has proved an ineffective route. The focus of the trials is on topical administration because of this and because of safety issues. Of course, it's early very, very early days. I also worry about potential side-effects (I actually have colitis, but have also heard of possible concerns regarding dementia, though haven't read anything to this fact). I believe that research will be coming out in a few months regarding early trials of the topical lotion. It's a long-shot. But at least it is something. Cheers Paul |
||
Reply With Quote |
"Thanks for this!" says: | Lerch (05-27-2019) |
03-05-2019, 06:52 AM | #5 | ||
|
|||
Junior Member
|
Quote:
|
||
Reply With Quote |
03-05-2019, 10:25 AM | #6 | ||
|
|||
Junior Member
|
|
||
Reply With Quote |
03-05-2019, 02:35 PM | #7 | ||
|
|||
Junior Member
|
Quote:
Last edited by IPN1967; 03-05-2019 at 07:11 PM. |
||
Reply With Quote |
03-05-2019, 08:55 PM | #8 | ||
|
|||
Junior Member
|
Quote:
Phase 2 human trials are currently taking place on human subjects: Pipeline - WinSanTor Current focus is on diabetic PN, with an intent to move to chemo- and HIV-related. |
||
Reply With Quote |
"Thanks for this!" says: | Lerch (05-27-2019) |
Reply |
|
|